SMSLIFE Stock Overview
Manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
SMS Lifesciences India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹801.80 |
| 52 Week High | ₹948.00 |
| 52 Week Low | ₹472.05 |
| Beta | 0.63 |
| 1 Month Change | 21.23% |
| 3 Month Change | 25.64% |
| 1 Year Change | 51.28% |
| 3 Year Change | 1.27% |
| 5 Year Change | 88.81% |
| Change since IPO | 494.59% |
Recent News & Updates
Recent updates
SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 13
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24Shareholder Returns
| SMSLIFE | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.5% | 1.7% | 2.7% |
| 1Y | 51.3% | 53.9% | 44.9% |
Return vs Industry: SMSLIFE underperformed the Indian Pharmaceuticals industry which returned 53.9% over the past year.
Return vs Market: SMSLIFE exceeded the Indian Market which returned 44.9% over the past year.
Price Volatility
| SMSLIFE volatility | |
|---|---|
| SMSLIFE Average Weekly Movement | 8.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: SMSLIFE's share price has been volatile over the past 3 months.
Volatility Over Time: SMSLIFE's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 567 | Talluri Veera Venkata Murthy | www.smslife.in |
SMS Lifesciences India Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers APIs in various therapeutic areas, such as antiulcer, erectile dysfunction, anti-gout, anesthesia, anti-infective, anti-obesity, antifungal, anti-convulsant, anti-emetic, ophthalmic, anti-worm, and antiemetic. It also exports its products.
SMS Lifesciences India Limited Fundamentals Summary
| SMSLIFE fundamental statistics | |
|---|---|
| Market cap | ₹2.42b |
| Earnings (TTM) | ₹90.93m |
| Revenue (TTM) | ₹3.06b |
26.7x
P/E Ratio0.8x
P/S RatioIs SMSLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMSLIFE income statement (TTM) | |
|---|---|
| Revenue | ₹3.06b |
| Cost of Revenue | ₹2.09b |
| Gross Profit | ₹971.66m |
| Other Expenses | ₹880.73m |
| Earnings | ₹90.93m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 30.08 |
| Gross Margin | 31.76% |
| Net Profit Margin | 2.97% |
| Debt/Equity Ratio | 50.5% |
How did SMSLIFE perform over the long term?
See historical performance and comparison